
|Articles|February 16, 2021
Raremark Rebrands as Xperiome
Advertisement
Raremark has announced that it is rebranding as Xperiome. Jeremy Edwards, CEO of Xperiome, commented, “Strategically, we are rebranding because we have two very different audiences, with individual needs that will benefit from equal attention and focus.”
Xperiome will now become the name and corporate identity of the company, while the Raremark brand will solely represent its patient-facing activities dedicated to helping people better understand, talk about and manage rare diseases.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Moving Beyond Historical Site Data to Real-Time Patient Insight
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
How Community Sites Can Stay Competitive Under Growing Efficiency Pressures
5



